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resumo 
 
 
O grafeno representa um dos alótropos de carbono. As suas características 
físico-químicas conferem-lhe propriedades únicas: elevada área superficial, 
condutividades elétrica e térmica excecionais, grande resistência mecânica, 
capacidade de bio-funcionalização e produção em massa. Todas estas 
qualidades tornam o grafeno amplamente aplicável e por isso é necessário 
investigar detalhadamente os seus possíveis efeitos adversos no contexto da 
saúde humana. Neste estudo foi avaliado o potencial citotóxico das 
nanoplaquetas de grafeno em células do pulmão (linha celular A549). As 
células foram cultivadas in vitro e expostas a várias concentrações de grafeno 
na forma de nanoplaquetas (5, 10, 25, 50, 100 µg/ml) durante 24h. A 
viabilidade celular, analisada pelo ensaio WST-8, não diminuiu com a 
exposição às nanoplaquetas de grafeno, tendo, porém, sido verificado um 
aumento da proliferação celular para a dose mais baixa. A produção de ROS, 
bem como a dinâmica do ciclo celular das células A549 também não foram 
afetados pela exposição às nanoplaquetas de grafeno. Os estudos da 
internalização celular das nanoplaquetas de grafeno por variação da dispersão 
lateral da luz mostraram que para a concentração mais elevada (100µg/ml) 
ocorreu um aumento significativo da internalização destas partículas. Por 
último, não se verificou indução de apoptose nas células A549 após 24h de 
exposição às nanoplaquetas de grafeno. De uma forma geral, estes resultados 
sugerem que as nanoplaquetas de grafeno não induzem toxicidade na linha 
celular A549. 
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abstract 
 
Graphene is one of the carbon allotropes. Its physical and chemical 
characteristics provide unique properties: high surface area, exceptional 
electrical and thermal conductivities, high mechanical strength, ability to bio-
functionalization and mass production. All these qualities make graphene 
widely applicable and, therefore, it is necessary to thoroughly investigate their 
possible adverse effects in the context of human health. This study evaluated 
the cytotoxic potential of graphene nanoplatelets in lung cells (cell line A549). 
The cells were cultured in vitro and exposed to various concentrations of 
graphene nanoplatelets (5, 10, 25, 50, 100µg/ml) for 24h. Cell viability, 
assessed by WST-8 assay, did not decrease after exposure to graphene 
nanoplatelets, however, an increase in cell proliferation for the lowest 
concentration was observed. ROS production as well as cell cycle dynamics of 
A549 cells were not affected by graphene nanoplatelets exposure. Cellular 
uptake of the graphene nanoplatelets, evaluated by changes in light side 
scatter by flow cytometry, increased significantly for the highest concentration 
(100µg/ml). In addition, there was no induction of apoptosis in A549 cells after 
24 hours of exposure to the graphene nanoplatelets. Overall, these results 
suggest that graphene nanoplatelets do not induce toxicity in cell line A549. 
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1. Introduction 
 
1.1. Historical Overview 
Nanotechnology is a science that works on the design, synthesis, development, fabrication 
and characterization of materials at the nanoscale (Venugopal et al. 2016). It includes areas 
such as physics, chemistry, biology, material science, health sciences and engineering 
(Nikam et al. 2014).  
The interest on nanomaterials started a long time ago, when Richard Zsigmondy proposed 
the concept of “nanometer”, having won the 1925 Nobel Prize Laureate in Chemistry 
(Hulla et al. 2015). After this, the term “nanotechnology” emerged in 1959, when a 
physicist called Richard Feynman spoke at an American Physical Society meeting 
(Tarafdar et al. 2013). In this meeting, he presented a lecture titled “There’s plenty of room 
at the bottom”, introducing the idea of manipulating matter at the atomic level (Hulla et al. 
2015). In 1974, Norio Taniguchi, from the Tokyo University of Science, defined 
“nanotechnology” as a technique that consists in separation, consolidation and deformation 
of elements by one atom or by one molecule (Tarafdar et al. 2013). Later, in the 1980s, K. 
Eric Drexler contributed to the development of the nanoscale phenomena through speeches 
and books (Tarafdar et al. 2013). Since that, the interest in the fields of nanoscience and 
nanotechnology has been increasing exponentially, with global investments in research and 
a high number of patents filing related to the technology and products developed within 
this field (Tarafdar et al. 2013). 
 
1.2. Applications of Nanotechnology 
Nanotechnology is an area that is constantly developing. With a high commercial and 
academic interest, new studies arise every day that seek to apply the extraordinary features 
of nanomaterials in our daily life. 
Nanotechnology can be applied for example to renewable energy, avoiding crises that may 
result from the exhaustion of fossil fuels (Salamanca-Buentello et al. 2016). The use of 
photovoltaic technology to capture solar energy (solar cells) is presented as a form of 
energy sustainability where photovoltaic nanostructures are applied (Mao et al. 2007). 
Most nanotechnology applications are related to human health care. The demand for 
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cheaper and effective medical treatments has led to extensive research and to the 
development of new technologies. Nanomedicine has the function to improve methods and 
bring technological advances so that health care services can be more efficient 
(Chakraborty et al. 2011). It gives the opportunity to better understand how human body 
works and provides tools to fight diseases like cancer. This is a field in expansion and it 
seeks to respond to the challenges posed by medical science, with special focus on 
diagnosis, drug delivery systems and patient care (Sahoo et al. 2007). Agriculture is 
another domain in which nanotechnology can be applied to the development of new tools 
for the detection and treatment  of diseases and the improvement of plants in their 
efficiency to absorb nutrients (Rai et al. 2012). The use of nanomaterials can help solve 
problems like pests and improve insecticides and pesticides (Rai et al. 2012). The use of 
nanotechnology in the food sector still raises some concerns from consumers. However it 
can be applied, for example, in the packaging of goods, constituting protective barriers 
against gases and bacteria; the use of nanossensors for the detection of contaminants is 
another strategy for enhancing foods (Duncan 2011). Access to potable water has become a 
concerning issue, mostly in less developed countries. The employment of membranes and 
filters based on carbon nanotubes, nanoporous ceramics, magnetic nanoparticles and other 
nanomaterials, has already been implemented for the removal of contaminants in water 
(Hillie et al. 2007). Nanoremediation is a field of nanoscience that attempts to solve 
problems related to the environmental rehabilitation, applying reactive nanomaterials for 
transformation and detoxification of pollutants (Karn et al. 2009). 
Man has always been exposed to nanoparticles (NPs) in the air, however with the industrial 
revolution this exposure increased due to the wide use of thermal degradation sources, such 
as power stations and internal combustion engines (Oberdörster et al. 2005). With the 
appearance and development of nanotechnology, exposure to NPs have increased, either by 
inhalation, ingestion, skin contact or injection. The NPs have unique physical, chemical 
and mechanical characteristics, which give them a high potential for numerous 
applications. However, these same properties, which apparently are ideal for use in 
industry and medicine, are likely to be harmful when they interact with cells. 
In addition to NPs found in the air, some workplaces are also capable of produce them in 
quantities which can range up to several hundred micrograms per cubic meter (Oberdörster 
et al. 2005). Inhalation is the major route of exposure, still it is necessary to take into 
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account the intake and skin contact during manufacture or use of these nanomaterials. Over 
the years and due to the expansion of these nanomaterials, the interest their potential side 
effects on human health has increased. 
Nowadays, the nanomaterials play a major rule in the economy, either by their values and 
their applications. They have a wide range of applications: solar panels, catalysts, tumor 
therapies, electronics and batteries. One of the major aims of the utilization of 
nanomaterials is the improvement of quality of life by refining existing materials and 
products. 
 
1.3. Nano – words definitions 
Nanomaterials can be divided into two major classes: natural and anthropogenic 
nanomaterials (Dhawan et al. 2010). Natural nanomaterials exist in Nature, for example as 
soil colloids (clay minerals, metal oxides, etc.), crystals of sea salt, and others. The 
anthropogenic nanomaterials can be further classified as incidental (nanomaterials 
manmade unintentionally – road and air transports) and as manufactured (nanomaterials 
produced because of their properties) (Dhawan et al. 2010). 
 The term nanomaterial does not have a single definition (Boholm et al. 2016). To the 
scientific research, definitions are very important since they allow replication and precise 
critical evaluation (Boholm et al. 2016). 
Many definitions have been proposed, for example, the United Kingdom Department for 
Innovation, Universities and Skills (UK DIUS), defines a nanomaterial as “a material 
having one or more external dimensions in the nanoscale or which is nanostructured” 
(British Standards Institution 2007); the Scientific Committee on Emerging and Newly 
Identified Health Risks (SCENIHR) describes a nanomaterial as “any form of material that 
is composed of discrete functional parts, many of which have one or more dimensions of 
the order of 100 nm or less” (SCENIHR 2007); the European Commission adopted a 
definition of a nanomaterial in 2011 (Potočnik 2011)  that characterizes a nanomaterial “as 
a natural, incidental or manufactured material, containing particles in the unbound state or 
as an aggregate or an agglomerate, and where, for 50% or more of the particles in the 
number size distribution, one or more external dimensions is in the size range 1nm – 
100nm”. 
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In addition to nanomaterial, there are other important terms regarding to nanotechnology 
(Khanna 2016): 
 Nano-object – it is a common term applied to all distinct nanoscale objects; it refers 
to an object with one or more dimensions in the nanoscale. 
 Nanoparticle – it is basically a nano-object with its three dimensions in the 
nanoscale. 
 Nanoplate – it has one dimension in the nanoscale, but the other two are much 
wider. 
 Nanofiber – it has two dimensions in the nanoscale and the third dimension is wider 
than the first. 
 Nanotube – it can be considered as an unfilled nanofiber. 
There is some controversy about the nano-words and the absence of a single definition can 
be a problem for the scientific progress and regulation (Boholm et al. 2016); however, it is 
important to point that the manipulation of the nanomaterials is covered by laws to ensure 
safety and health to workers and protection to the environment. 
 
1.4. Carbon and its allotropes 
Carbon is the most important element found on Earth, and it yields the basis of all living 
organisms. Organic carbon it’s found in animals and plants as a constituent of proteins, 
amino acids, lipids and nucleic acids. After millions of years, it can be transformed into 
fossil fuels (Loos 2015). Inorganic carbon is present in diamonds, pencils, lubricants and 
polymeric materials (Loos 2015). Carbon has wide technological application, varying from 
biomedicine to synthetic materials, due to its capacity to bind to itself and to almost all the 
elements (Hirsch 2010). 
Basic carbon forms exist in two natural allotropes: diamond and graphite (Hirsch 2010). 
Diamond has a cubic and hexagonal configuration and represents sp3-hibridized carbon 
atoms (Loos 2015; Hirsch 2010). Graphite is a very stable thermodynamic material and its 
structure is formed of sheets of atoms with an hexagonal arrangement, known as graphene 
(Loos 2015) (Figure 1).  
5 
 
Fig. 1. Schematic representation of carbon allotropes: a) graphite, b) diamond, c) fullerene, 
d) carbon nanotubes, e) graphene (adapted from Loos 2015). 
 
 
In 1985, Kroto et al. discovered a new allotrope, called fullerene (C60), which is composed 
of a hollow cluster with 60 carbon atoms (or more), disposed as hexagons and pentagons 
(Loos 2015). Because of this discovery, Robert F. Curl Jr., Sir Harold Kroto and Richard 
E. Smalley were awarded with the 1996 Nobel Prize in Chemistry. For their application, 
fullerenes are chemically functionalized, because this confers them exclusive properties, 
such as increased solubility in any solvent (Hirsch 2010). 
A few years later, Iijima (1991) synthesized another allotrope, the carbon nanotubes 
(CNTs), consisting of needle-like tubes. CNTs can be single-walled or multi-walled and 
usually they have diameters in the order of one or two nanometers, but can be a few 
millimeters in length (Hirsch 2010). CNTs are chemically resistant, the electrical 
conductivity can be controlled and they can produce refined molecular structures 
(Takamura 2009). 
Finally, in 2004, Andre Geim and Konstantin Novoselov were able to prepare single-
graphene layers by simple mechanical exfoliation of graphite (Novoselov et al. 2004). The 
isolation of this major carbon allotrope awarded them the 2010 Nobel Prize in Physics. 
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1.4.1. Graphene  
When graphene was described, it immediately proved to be a compound of great potential 
due to all their physicochemical properties (Novoselov et al. 2004). Graphene consists of a 
monolayer of carbon atoms rearranged in a bi-dimensional honeycomb-like structure 
(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
Until the discovery of graphene, it was assumed that bi-dimensional compounds were 
thermodynamically unstable unless they were part of a 3D structure (Geim et al. 2007). 
The isolation of graphene showed that the crystals had a high quality and were stable, 
showing that it would be possible to have reliable 2D materials (Novoselov et al. 2004; 
Geim et al. 2007). 
Mechanical exfoliation (repeated peeling) was the technique first used to isolate graphene 
films, resulting in graphene films of about 10 µm in size (Novoselov et al. 2004). It is also 
possible to isolate graphene through chemical exfoliation, interspersing graphite with 
atoms and molecules so that their sheets are separated layer by layer. Furthermore, 
graphene can be obtained by Molecular Beam Epitaxy (MBE), which offers viable ways to 
produce graphene for electronic applications (Geim et al. 2007). However, even with all 
the existing techniques and all efforts to improve them, the mechanical exfoliation is still 
the technique that produces graphene with higher quality (Singh et al. 2011). 
An extensive work is being done to understand all the potentials of graphene. It has special 
interest due to its exceptional properties. The optical properties of graphene are related to 
its unique electronic structure, showing an absorption of 2.3% of incident light, comprising 
Fig. 2. Graphene has a bi-dimensional honeycomb-like structure. 
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a wide wavelength range (Nair et al. 2008). Besides this, graphene has photoluminescence 
that can be used in cellular imaging (Sun et al. 2008). Once again, the bi-dimensional 
honeycomb-like structure, only a single-atom-thick provides exclusive electronic 
properties to graphene (Geim et al. 2007). This structure results in the Dirac point, where 
two bands combine (Chang et al. 2013). As electrons propagate through the carbon grid, 
they lose their mass completely, causing them to behave as relativistic particles (Chang et 
al. 2013). The mechanic properties of graphene are also extraordinary, following carbon 
nanotubes, it is the element with highest elastic modulus and strength (Singh et al. 2011). 
The perfect graphene single-atom-layer is flawless, causing it to have an intrinsic 
resistance similar to that of graphite (Singh et al. 2011). In terms of thermal properties, the 
single-atom-layer of graphene presents the highest thermal conductivity at room 
temperature (Balandin et al. 2008).      
1.4.1.1. Applications 
Because of its unique characteristics, graphene is an impressive material (Geim et al. 
2007). Its physical and chemical properties increase the interest of scientists around the 
world and in different areas. 
The physical properties of graphene make it an excellent material for applications on 
electronics and its high carrier mobility has gained greater attention (Avouris et al. 2012). 
Graphene has been applied in components such as transparent conductive coatings like 
touch-screen displays, e-paper and organic-emitting diodes (OLEDs) (Novoselov et al. 
2012). The electronic products demand for a high transmittance and a low sheet resistance 
that are present in graphene. Due to his high conductivity, graphene has also been used to 
develop ultra-thin transistors (Mattevi et al. 2012). Supercapacitors (Liu et al. 2010) are 
also an area of interest since they are energy store devices that provide high currents. This 
supercapacitors can be applied for example to power electric cars (Randviir et al. 2014). 
Another potential application of graphene are photovoltaic cells, or solar cells (Wang et al. 
2013). Along with great electronic properties, graphene has particular optical features over 
an ample wavelength range. Graphene photodetectors are widely studied (Mueller et al. 
2010; Xia et al. 2009) and they can be used in a broad range, from ultraviolet to infrared 
wavelengths (Novoselov et al. 2012). 
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As a result of an unique bi-dimensional structure, graphene becomes very sensitive to the 
environment and because of that it is used for sensor applications (Novoselov et al. 2012). 
Studies have demonstrated the ability to detect a diversity of molecules like gases (Dan et 
al. 2009; Robinson et al. 2008) and biomolecules (Ohno et al. 2009; Mohanty et al.2008).  
Graphene’s features make it a potential compound for bio-applications. Single-layered 
graphene has been the subject of investigation for its possible application on drug and gene 
delivery. Owing to the large surface area and easy surface functionalization, graphene and 
its derivate have been considered as a possible choice for multimodal imaging allying 
cancer photothermal and chemo- and/ or photodynamic therapies (Yang et al. 2015). The 
first demonstration of the use of graphene oxide for drug delivery was made by Liu and its 
group in 2008 (Liu et al. 2008). They found that nano-graphene oxide functionalized with 
polyethylene glycol (PEG), was physiologically stable and that there was no obvious 
toxicity for the concentrations tested, indicating that nano-graphene oxide alone was not 
toxic. Nowadays the applications of graphene have extended to many studies in drug 
delivery, bio-imaging and biosensors (Feng et al. 2013; He et al. 2010; Jung et al. 2010).  
Furthermore, graphene has also potential to be used in the field of regenerative medicine 
and tissue engineering (Nayak et al. 2011). Park (2011) and co-workers found that 
graphene could be used to stimulate the differentiation of human neural stem cells (hNSCs) 
Fig. 3. Main fields of application of graphene. 
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in neurons instead of glia. Therefore these studies support the use of graphene as a scaffold 
for stimulating NSC adhesion and differentiation, and also for neural prosthetics in neural 
regenerative medicine.  
In virtue of its one-atom-thick layer, conductivity and strength, graphene is an excellent 
support for imaging biomolecules in transmission electron microscopy (TEM) (Nair et al. 
1993). Graphene has a very organized and stable structure and these features make it a 
good support layer.  
Graphene-based nanomaterials have also been capturing the attention for environmental 
purposes (Perreault et al. 2015). These materials have been used as electrodes materials for 
contaminant monitoring or removal (Zhao et al. 2011; Yan et al. 2014), sorbent or 
photocatalytic materials for decontamination (Gao et al. 2012) and as new materials for 
water treatment and desalination membranes (Ning et al. 2012). 
In addition to all these properties, graphene has also been referred as the most recent 
antibacterial agent (Liu et al. 2011). However, its antibacterial effect is still controversial 
(Hegab et al. 2016), lacking more studies and analysis in this area. 
1.4.1.2. Graphene-family nanomaterials 
The intense research and the growing development of applications for graphene have led to 
the production of graphene derivatives, the so-called Graphene-Family Nanomaterials 
(GFNs). Graphene-derived materials may differ in surface chemistry, layer number, 
composition, lateral dimension, purity and defect density (Sanchez et al. 2012). 
 
- Bilayer graphene, trilayer graphene: it consists in a stack of 2 or 3 graphene 
layers that are well-defined (Bianco et al. 2013).  
- Few-layer graphene (FLG): it can be defined as stacked graphene sheets, usually 
2-5 layers (Bianco et al. 2013). 
- Multi-layer graphene: like the above, it’s a bi-dimensional structure with 2 to 10 
graphene monolayers stacked and well-visible (Bianco et al. 2013). 
- Ultrathin Graphite: it is a material with more than 10 graphene sheets stacked (3-
5nm) but less than 100 nm. It is considered a nanomaterial since it has at least one 
dimension in the nanoscale (1-100nm) (Sanchez et al. 2012). 
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- Exfoliated Graphite: this definition is based on the manufacturing process. It’s a 
material produced from a partial exfoliation of graphite, resulting into thin parcels 
with the original 3D stacking of graphite (Bianco et al. 2013). 
- Graphene Nanosheet (GN): it is a single-layer of graphene in suspension or 
adhered to a substrate (Bianco et al. 2013). 
- Graphene Microsheet: it is a material similar to that previously described, but its 
dimensions range from 100nm to 100µm (Bianco et al. 2013). 
- Graphene nanoribbon: it is a single-atom-thick band of carbon atoms where the 
longer lateral dimension exceed the width by at least one order of magnitude 
(Bianco et al. 2013). 
- Graphene Quantum dots (GQDs): it is a term used to describe few-layered 
graphene nanosheets in studies about photoluminescence. Its lateral dimensions are 
<10nm (Bianco et al. 2013). 
- Graphene Oxide (GO): it is a graphene monolayer that has a functionalized 
surface, with an elevated content in oxygen (Sanchez et al. 2012). This material is 
produced by oxidation and exfoliation of graphene (Bianco et al. 2013). 
- Graphite Oxide: it is a solid material resulting from the oxidation of graphite. This 
material can be used to produced graphene oxide monolayers (Bianco et al. 2013). 
- Reduced Graphene Oxide (rGO): it is formed by reducing the oxygen content of 
graphene oxide (Bianco et al. 2013). This process is applied in order to build up the 
electrical conductivity and alter other GO properties (Sanchez et al. 2012). 
- Nano-GO: normally describes graphene oxide with small lateral dimensions (20-
100nm). Owing to its small size, it can be used for biological applications: it is a 
stable material and it easily enters the cell (Sanchez et al. 2012).     
1.4.1.3. Graphene’s Toxicology 
Nanomaterials have been widely used in consumer and industrial products and this 
situation brings up many questions regarding their interaction with biological systems and 
consequently, the associated risks. Because of that, a lot of studies have been made, trying 
to elucidate us about the possible hazards of these materials. One important thing is the fact 
that the toxicity experiments are prepared and standardized for studies in chemical 
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products (Kroll et al. 2009). The nanoparticles have a lot of exclusive physicochemical 
features that may cause some conflicts to the classical toxicity assays (Dhawan et al. 2010). 
As described above GFNs are emergent materials with applications in many areas. Because 
of their extensively manufacturing in the last years, the probability of human exposure by 
inhalation, ingestion, dermal penetration and injection or implantation has dramatically 
increased (Xia et al.  2009). 
Some studies have reported cytotoxicity of GFNs in many bacteria, mammalian cells and 
animal models. Graphene oxide and reduced-graphene oxide are the most studied 
graphene’s derivates because of their high solubility/dispersibility/stability in water, when 
compare to other GFNs (Guo et al. 2014).  
Hu and co-workers (2010) showed the antibacterial power of graphene-based paper and 
that it can be produced with high inhibition ability to bacteria growth. Neural 
Phaeochromocytoma-derived PC12 cells were used to compare toxicity between graphene 
and single-wall carbon nanotubes (SWCNTs) (Zhang et al. 2010). In this study was 
demonstrated that both graphene and SWCNTs induced cytotoxic effects and the effects 
were dependent of the concentration and the shape of the graphitic material. Exposure to 
SWCNTs greatly increased the LDH release when compared to graphene, while exposure 
to graphene induced the generation of ROS and caspase-3 activation indicating apoptosis 
induction (Zhang et al. 2010). Jaworski et al. (2013) evaluated the toxicity of graphene 
platelets (GP) on U87 and U118 glioma cells, by analyzing the effect of this nanomaterial 
on the morphology, viability, membrane integrity and mechanisms of cell death. GP 
proved to be toxic for glioma cells, but apoptosis was only triggered in U118 cell line. 
Nevertheless, due to the large surface area of the GP (between 450nm and 1.5µm – not at 
nanoscale) they were not observed inside the cells. Kunming mice were used to study in 
vivo the toxicity of GO with doses of 0.1, 0.25 and 0.4mg/kg for 1 day, 7 days and 30 days, 
respectively (Wang et al. 2011). At small concentration (0.1 and 0.25 mg/kg) doses, the 
GO exposed intravenously, showed no toxicity, however a higher dose (0.4 mg/kg) caused 
chronic toxicity. Mortality was observed due to obstruction of the major airways as 
consequence of GO accumulation. Tissue analysis showed lung inflammation and 
formation of epithelial granulomas. The results also demonstrated accumulation of GO in 
liver.  
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Inhalation is one of the major means of exposure to graphene nanomaterials. The 
inhalation toxicity of graphene nanoplatelets (GNP) and carbon black was analyzed in 
C57BL/6 mice (Schinwald et al. 2012). Mice were treated by pharyngeal aspiration, 
intrapleural injection, succeeded by lavaging the lung and pleural space. After exposure 
with GNP, it was observed an increase in pro-inflammatory cytokines, in contrast with 
carbon black and control. 
The characterization of nanomaterial to be tested is of extreme importance and the size is 
the most essential parameter; it is crucial for understand the interactions with biological 
systems (Dhawan et al. 2010). Among the several techniques used to evaluate the 
nanoparticles sizes, the most frequent are Brunauer-Emmett-Teller (BET), transmission 
electron microscopy (TEM), scanning electron microscopy (SEM), dynamic light 
scattering (DLS) and atomic force microscopy (AFM) (Dhawan et al. 2010). 
 
2. Assay techniques and biomarkers to access nanoparticle toxicity 
 
For correct assessment of the risks involved in the production and use of nanomaterials, it 
is essential to understand their effects on human health and quantify the levels of exposure 
(Oberdörster et al. 2007). The characteristics of nanoparticles can pose great challenges to 
the techniques used in toxicology and because of that it is important to have standards 
procedures, with controlled conditions (Kalantzi et al. 2014). 
One of the most important steps for the study of nanoparticle cytotoxicity is the 
characterization of these nanoparticles. This information will allow to better understanding 
the interactions between the nanoparticles and the cells. Dynamic light scattering measures 
the hydrodynamic diameter of the NPs and it is possible to doing it in circumstances that 
simulate the exposure conditions. The AFM is an instrument that gives information about 
several properties of NPs: morphology, size, surface texture and roughness.  
In vitro assays, using cell cultures, are widely used methods to evaluate the cytotoxicity of 
various compounds in cellular systems. The in vitro studies can include methods for 
measuring the metabolic activity of cells, using colorimetric assays. Other methods like 
LDH assay provides information about the integrity of the cell membrane. Bioluminescent 
methods are also used to assess  the number of viable cells, with neutral red or TrypanBlue 
(Kalantzi et al. 2014). The study of cell cycle progression is also a very important method 
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in the evaluation of cytotoxicity of nanomaterials. These studies allows to understand if the 
exposure to nanomaterials may or may not interfere with the normal functioning of cell 
cycle. The production of reactive oxygen species (ROS) is one of the major mechanisms of 
nanoparticle toxicity and therefore it is essential to evaluate the amount of ROS produced 
by the cell upon nanomaterials exposure. Another essential parameter to consider in a 
toxicological assay is the NPs cellular uptake. This will allow the understanding of 
biological effects that NPs can cause. Cell death is also a parameter that can be analyzed in 
in vitro studies. 
Toxicologists use in vitro studies always as a first approach instead of in vivo, because they 
provide faster results, they are less expensive and more convenient and besides that, there 
are no ethical issues to deal with. However, and because the methods are settled for 
chemicals, they must be applied with caution considering the physicochemical properties 
of NPs. It is also fundamental to consider that during the manufacturing process or 
managing in the laboratory, contaminants may be introduced and so alter the results 
(Dhawan et al. 2010).  
 The following sub-sections will describe some of these techniques in more detail: 
 
2.1. Cell viability – WST-8 
Cell viability studies are normally performed to understand if a given compound affects 
cell proliferation or show direct cytotoxic effects that eventually lead to cell death. There 
are a wide variety of experiments that can be performed to assess the viability of 
eukaryotic cells. One of the most common is based on tetrazolium compounds, as for 
instance MTT, MTS, XTT or WST series, that are used for evaluate the metabolic level of 
the cells (Riss et al. 2004). These assays require the cell incubation with the tetrazolium 
reagent that will be converted to a colored product that can be detected with a plate reader. 
The signal is directly proportional to the amount of viable cells in that population (Riss et 
al. 2004). If the cells are not viable, there is no reduction of the substrate and therefore, no 
signal is emitted. The signal intensity will depend on many factors such as the 
concentration, the incubation time, the amount of viable cells and their metabolic activity 
(Riss et al. 2004). 
The MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide] assay is 
one of the most widely used techniques to ascertain cell viability. MTT is reduced mostly 
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by NADH of metabolically active cells, that convert MTT into an intense purple colored 
formazan compound, which is water insoluble (Riss et al. 2004), therefore, it has to be 
solubilized before the absorbance measurement (Tominaga et al. 1999). This further step in 
the protocol makes it more time-consuming, which can represent a disadvantage. The other 
tetrazolium reagents, such as MTS, XTT and WST series are soluble in cell culture 
medium, which makes the assay procedure much more simple (Riss et al. 2004).  
In this study it was used the WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt], which is a very responsive, stable 
salt and it is easy to synthesize (Ishiyama et al. 1997) (Figure 4). As described by 
Tominaga et al. (1999), the WST-8 has a higher sensitivity when compare with 
conventional tetrazolium salts. 
 
 
 
 
 
 
Fig. 4. The WST-8 is a highly water-soluble tetrazolium salt that is reduced to an 
orange-coloured formazan dye in viable cells. The figure shows a 96-well plate 
used in this study. 
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2.2. Cell cycle analysis 
The cell cycle is a succession of events in a cell that lead to duplication of all of its 
elements and to its division in two daughter cells (Dubitzky et al. 2013). The cell cycle is 
conventionally divided into five phases: G0 (Gap), G1 (First Gap), S Phase (Synthesis 
Phase), G2 (Second Gap) and M Phase (Mitosis) (Figure 5). G1 is characterized by an 
intensive biosynthetic activity of proteins, enzymes and RNA followed by a cell growth; S 
Phase is the synthesis phase during which the DNA is synthesized and replicated; G2 is a 
period of synthesis of biomolecules necessary to the cellular division that is followed by 
the mitotic phase (M Phase) (Jayat et al. 1993). Non-proliferating cells enter a quiescent 
state at G1 that prevents further divisions – the G0 Phase. During the cell cycle, it is 
required a regulation, to guarantee that all the steps follow the right direction. The cell does 
this regulation through the cell cycle checkpoints. There are two important checkpoints: 
the first ensures the right DNA replication (at the G1 to S checkpoint), and the second 
ensures the successful completion of the early mitoses (at G2 to M checkpoint) (Dubitzky 
et al. 2013). There’s also a third checkpoint at the M phase and it guarantees that each 
daughter cell receives a complete copy of the genome (Ciliberto et al. 2009). These 
checkpoints work through a machinery of complexes of cyclins and cyclin-dependent 
kinases (Dubitzky et al. 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 5. Schematic representation of cell cycle and its checkpoints for DNA 
damage control (adapted from Chin et al. 2010). 
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Flow cytometry is used to analyze various cellular components, organelles and functions, 
and it is widely used to study the cell cycle by taking DNA content into account (Jayat et 
al. 1993). The cell cycle analysis allow us to estimate the portion of cells that are in each 
phase through analytical processes (Dubitzky et al. 2013) (Figure 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These studies are carried out with specific DNA dyes and it is accepted that the 
fluorescence emitted is proportional to DNA content in the cells (Kerker et al. 1982). If the 
cells are in the G1 phase, the DNA content will be 1x and it will form a peak in the DNA 
distribution; if cells are in G2 phase, the DNA content will be 2x and it will form a peak in 
the DNA distribution twice the peak of G1. The cells in the S phase will have an 
intermediate DNA distribution (Gray et al. 1986).  
Flow cytometry gives us information by analyzing cell by cell and so it is possible to do a 
targeted study, with quantitative information, quick and accurate (Jayat et al. 1993). 
 
Fig. 6. Cell cycle profile of A549 by flow cytometry. 
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2.3. Intracellular ROS detection 
Reactive Oxygen Species (ROS) are small, short-lived and highly reactive molecules, 
formed by incomplete one-electron reduction of oxygen (Scherz-Shouval et al. 2007). This 
group contains oxygen anions, free radicals, such as superoxide and hydroxyl radical, and 
peroxides, such as hydrogen peroxide (H2O2) (Scherz-Shouval et al. 2007). ROS are 
continuously produced under normal conditions as a consequence of aerobic respiration 
(Eruslanov et al. 2010). They are also involved in enzymatic reactions, mitochondrial 
electron transport, signal transduction, activation of nuclear transcription factors, gene 
expression and the antimicrobial action of neutrophils and macrophages (Bayr et al. 2005). 
However, the generation of reactive oxygen species is an important mechanism of 
nanotoxicity, inducing oxidative stress in cells (Fu et al. 2014). 
Free radical processes are involved in cellular physiology and pathology and therefore it is 
essential to use a method to quantify the production of ROS in living cells (Jakubowski 
2000). The most common techniques use cell permeable fluorescent and chemiluminescent 
probes. 2’-7’-dichlorodihydrofluorescein diacetate (DCFH-DA) is one of the most widely 
used probes for measuring the redox state of a cell. DCFH-DA is cell permeable and a non-
fluorescent precursor of DCF (2’-7’-dichlorofluorescein) that is used as an intracellular 
probe (Eruslanov et al. 2010). This probe is very sensitive to changes in the redox state of 
the cell and can be used to monitor ROS over time (Eruslanov et al. 2010). 
After adding DCFH-DA to the cells, it diffuses across the cell membrane and it is 
hydrolyzed by intracellular esterases, to release DCFH, which reacts with oxidizing 
species, forming an extremely fluorescent compound, DCF (Rota et al. 1999), that can be 
detected either by fluorescence microscopy or flow cytometry (Figure 7). The redox state 
of the sample can be observed by the intensity of the fluorescence emitted (Eruslanov et al. 
2010). 
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2.4. Nanoparticle cell Uptake 
The nanoparticles have been the subject of several studies, due to their potential 
application in the medical field. One of the parameters to be considered is the interaction of 
these NPs with the cells and how these interactions can influence their uptake. The 
physical properties of NPs have a fundamental role in their entry into the cell, as well as all 
the biological environment and the characteristics of the cell membrane itself (Adjei et al. 
2014). There are numerous receptor-mediated pathways for the internalization of 
substances that may occur simultaneously (Figure 8).  
 
 
Fig. 8. Mechanisms of endocytosis for cell uptake. 
Fig. 7. Detection of intracellular ROS by flow cytometry. 
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One of the most common mechanisms for uptake is phagocytosis and it is present in 
various types of cells (Aderem et al. 1999). In mammals, phagocytosis act as a response of 
the immune system, engulfing all the unwanted particles in the organism (Silverstein 1995) 
(Figure 10). Phagocytosis works with the help of vesicles known as phagosomes, which 
have sizes greater than 250 nm (Rabinovitch 1995). The interaction of the cell receptors 
with unfamiliar particles can lead to the activation of this process; however, it can also be 
activated by means of opsonins that can attach the foreign particle and facilitates 
phagocytosis (Yameen et al. 2014). 
Pinocytosis is another mechanism used by cells for the uptake of substances and can be 
further divided in clathrin-mediated endocytosis, caveolae-mediated endocytosis and 
macropinocytosis (Yameen et al. 2014) (Figure 10).  
 
 
 
 
Clathrin-mediated endocytosis involves the formation of a clathrin coat around a vesicle 
(Murugan et al. 2015). The pathway is activated by the signaling of substances and then 
various proteins start to work on the formation of the vesicle. Clathrin is recruited from the 
cytosol to form the coat and finally, the vesicle detaches from the cellular membrane and 
goes to the interior of the cell (Figure 9). Once there, it releases the endocytosed 
substances (Xiang et al. 2012).  
Fig. 9. Illustration of the mechanism of clathrin-mediated endocytosis (adapted from Murugan et al. 
2015). 
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Caveolae-mediated endocytosis is a mechanism that initially forms a flask-like shape 
structure with the help of caveolins that bind with the cholesterol present in the cellular 
membrane (Kumari et al. 2010). The actin present in the cellular membrane is reorganized 
and dynamin is recruited from the cytosol to form the caveolae structure (Pelkmans et al. 
2002) (Figure 10). The internalization of the vesicle is similar to the clathrin-mediated 
endocytosis. 
 
 
 
 
Macropinocytosis is an independent process that allows the internalization of large 
volumes of extracellular fluids (Kerr et al. 2009). The actin present in the cellular 
membrane is polymerized, allowing the formation of protrusions that encapsulates the 
fluids (Kumari et al. 2010) (Figure 10). These protrusions fuse with the membrane forming 
macropinosomes (Kerr et al. 2009). The fate of the macropinosomes appears to be different 
according to the cell type that they are formed; they may enter the endosomal/lysosomal 
pathway or they can remain isolated within the cell (Kerr et al. 2009). 
The uptake of NPs at the cellular level can be assayed by flow cytometry. This technique 
combines two properties of scattered light laser: the forward-scatter (FS) and the side-
scatter (SS) (Figure 11).  
Fig. 10. Illustration of caveolae-mediated endocytosis, macropinocytosis and phagocytosis (adapted 
from Murugan et al. 2015). 
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The  intensity emitted by this two parameters is proportional to the size of cells (FS) and 
the intracellular density (SS) (Suzuki et al. 2007). In the experiment conducted by Suzuki 
and co-workers (2007), they concluded that cells which assimilated a larger number of NPs 
showed a higher SS. 
 
2.5. Apoptosis/ Necrosis 
Apoptosis consists of a mechanism of programmed cell death and it is essential during 
development and in the maintenance of homeostasis (Hollville et al. 2016). When a cell 
enters apoptosis there are many morphological modifications: cell shrinkage, bebbling of 
plasma membrane, nuclear chromatin condensation and fragmentation, with maintenance 
of organellar integrity (Mattson et al. 2012). Biochemical events also occurs like the 
upregulation of proapoptotic proteins such as Bax and Par-4; the release of cytochrome c; 
activation of effector caspases; externalization of phosphatidylserine (PS), which serves as 
a signal for apoptosis recognition (Mattson et al. 2012).  
Normally, necrosis occurs as the result of severe insults, such as trauma, cellular energy 
failure or toxicity (Mattson et al. 2012). In the course of necrosis, the changes that happen 
are different from apoptosis. The cell swells, the organelles lose their integrity and the 
nuclear membrane becomes disrupted; this process is also independent of proapoptotic 
proteins (Mattson et al. 2012).  
Apoptosis is usually an individual process, there is no release of cellular contents and the 
dying cell is engulfed by macrophages; on the other hand, during necrosis, the cell lyses 
and it releases its contents that can damage the surrounding cells (Mattson et al. 2012). 
Fig. 11. Analysis of incorporation of nanoparticles by the flow cytometric light scatter parameter. A) 
Control, B) Treatment. 
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Phosphatidylserine is a plasma membrane phospholipid concentrated on the inside (Fadok 
et al. 1998). When cells enter apoptosis, the plasma membrane lose its phospholipid 
asymmetry and expose PS on the surface of the membrane, which works as a marker for 
apoptosis (Fadok et al. 1992). Flow cytometry assays use the fluorochrome-labelled 
Annexin-V that binds to PS in a calcium-dependent manner (Fadok et al. 1998; Raynal et 
al. 1994). A vital dye such as propidium iodide (PI) can be combined with Annexin-V, to 
distinguish between live, apoptotic and necrotic cells, according to differences in 
membrane permeability (Vermes et al. 1995; Vermes et al. 2000). PI is not permeable to 
membranes and so, live and apoptotic cells are not stained (Vermes et al. 1995; Vermes et 
al. 2000; Darzynkiewicz et al. 1992). During late apoptosis or necrosis, the permeability of 
plasma and nuclear membranes changes and PI enters the cell and intercalates into DNA 
allowing the identification of the nucleus by emitting its characteristic red fluorescence 
(Vermes et al. 1995; Vermes et al. 2000; Darzynkiewicz et al. 1992). 
 
3. A549 Cell line 
A549 cell line comes from a human lung adenocarcinoma. It was first isolated in 1973 by 
Giard et al. (1973) from a cancerous lung tissue culture of a 58 years old Caucasian man. 
During its analysis, these cells showed multilamellar cytoplasmic inclusion bodies, a 
characteristic of Type II alveolar epithelial cells of the lung (Lieber et al. 1976). These 
cells are used as a research model on epithelial lung structures and in studies relating to the 
development of lung cancer (Jiang et al. 2010). In addition, these cells are one of the most 
applied model for toxicological studies in air pollution (Líbalová et al. 2014).  
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4. Aims 
 
The lung is the major route of entry of the nanoparticles in the human organism and so, it 
is important to understand the effects of the graphene nanoparticles on their cells. 
The general aim of the present dissertation was to evaluate the cytotoxic potential of 
graphene nanoplatelets on lung cells. 
The specific aims of this work were: 
 Characterization of the graphene nanoplatelets in terms of their physicochemical 
properties; 
 Evaluate the effects of graphene nanoplatelets on the cell viability on the human 
lung adenocarcinoma cell line (A549); 
 Evaluate the effects of graphene nanoplatelets on cell cycle progression; 
 Elucidate the type of eventual cell death induced by graphene nanoplatelets; 
 Evaluate the putative ROS induction in A549 cells by graphene nanoplatelets; 
 Assess the nanoparticle uptake by flow cytometry. 
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5. Material and Methods 
5.1. Graphene nanoplatelets 
Graphene nanoplatelets (GNPs) were purchased from Sigma-Aldrich® dispersed in H2O 
(1mg/ml). According to the manufacturer, there is a presence of a few-layer graphene 
flakes with an average of 5-7 atomic layers. 
 
5.2. Characterization of Graphene Nanoplatelets 
The hydrodynamic diameter of GNPs was measured by Dynamic Light Scattering – DLS – 
and the zeta potential was assessed by electrophoretic mobility, both measurements using a 
ZetaSizer Nano ZS (Malvern Instruments, UK). This method allows us to measure the 
hydrodynamic diameter (effective diameter of a particle in a liquid environment) of the 
particles in suspension in the cell culture medium and Milli-Q water. The concentration 
used was 10µg/ml and the reads were done at time zero, 2h, 4h and 24h.  
 
 
5.3. A549 cell line culture 
For this study, the human alveolar adenocarcinoma cell line A549 was used as a model. 
The A549 cell line was cultured in a 25 cm2 flasks (Corning®) with 5ml of Kaighn’s 
Modification of Ham’s F-12 Medium (F-12K), supplemented with 10% (v/v) Fetal Bovine 
Serum (FBS) (Gibco), 1% of penicillin-streptomycin (Gibco) and 1% Fungizone (Gibco). 
The cells were observed every day under the inverted microscope (Nikon®Eclipse TS100) 
to check if there was no contamination or any other problem with the culture and to 
understand its growth and confluence (% of cell coverage on the surface area of the culture 
vessel) state. Subculture was performed every 3-4 days, when cultures reached 
approximately 70-80% confluence. After removal of the culture medium, cells were 
washed with 5 ml PBS and incubated with 3 mL Trypsin-EDTA (0.25% trypsin, 1 mM 
EDTA) for 5 min, to cleave proteins that enable cell adherence to the flask and cell-cell 
adhesion. After cell detachment from the culture flask, trypsin was inactivated by adding 6 
mL supplemented medium to the culture. Cells were harvested, counted using a 
hemocytometer and seeded in a new flask with complete culture medium. The cultures 
were maintained at 37 °C in a 5% CO2 humidified atmosphere. 
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5.4. Graphene Nanoplatelets exposure 
Cells were seeded in multiwell plates and incubated for 24h at 37°C, 5% CO2, to adhere. 
After the incubation period, the medium was taken out and replaced for the same amount 
of the proper dilutions of GNPs. The time of exposure was normally 24h, with some assays 
with 4h of exposure. 
 
5.5. Cell viability – Cytotoxicity Assay: WST-8 
Cell viability was measured using the WST – 8 assay (Sigma-Aldrich®) by following 
manufacturer instructions, with some modifications. 
Briefly, in a 96 – well plate, one hundred µl of cells were seeded at the concentration of 
7x104 cells/ ml and incubated for 24h, at 37°C, 5% CO2 for cells adherence. After that, the 
culture medium was replaced by 100 µl of GNPs in growth medium at the following 
concentrations: 5, 10, 25, 50 and 100 µg/ml. Cells cultured in culture medium without 
GNPs were taken as the control. After 24h exposure, 10 µl of WST – 8 reagent were added 
to each well. Then, the plate was incubated for 1h at culture conditions and then the 
absorbance was measured at 450nm in a microplate reader (Biotek® - Gen5™ software). 
The cell viability was calculated using the equation, where A450 represents the absorbance 
of the sample read at 450nm: 
Relative % viability = A450 sample/ mean A450 control x 100 
Some alterations were then performed to this basic protocol (Protocol I) in order to 
minimize the putative interference of the particles with the assay. The first alteration 
(Protocol II) included a washing step with PBS (50 µl, for 30 seconds) following the 24h 
exposure, and then complete culture medium with WST – 8 reagent was added to each 
well. The plate was then incubated and analyzed as described above. An additional 
experiment to test the adsorption of the culture medium by GNPs on the toxicity was 
performed according to the procedure described by Chang et al. (2011) (Protocol III). 
GNPs samples at 5, 10, 25, 50 and 100 µg/ml were incubated in culture medium (without 
cells) at 37°C, 5% CO2, for 24h. Then, the GNPs suspensions were centrifuged at 400 rpm 
for 5 min. The supernatants were then collected and were used to expose the cells as 
described above. After 24h incubation, cell viability was assessed with the WST-8 assay. 
For this assay it was used a background control for each concentration and a blank. 
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5.6. Flow cytometric analysis of Cell Cycle 
Cell cycle distribution was analyzed according to the method previously described by 
Oliveira et al. (2014). Briefly, cells were seeded in 6 well plates each receiving 2 ml of 
suspended cells at the concentration of 1x105 cells/ml. They were allowed 24 hours to 
adhere and grow in the incubator before being exposed to GNPs at 5, 50, 100 µg/ml and 
the control. Each assay concentration consisted of three technical replicates. This was 
followed by an incubation time of 24h. Afterwards the media was removed and the cells 
were washed with PBS, trypsinized and ressuspended in media. The suspensions were 
collected to microtubes and centrifuged at 300g for 5 min. The supernatant was discarded 
and the cells were washed in PBS and finally ressuspended in 1 ml of cold ethanol 85% 
and then they were stored at -20°C until analysis. 
At the time of analysis, cells were centrifuged at 300g for 5 min at 4°C. Next, the 
supernatant was discarded and the cells were ressuspended in 800 µl of PBS. After this, the 
suspension was filtered through a 55 µm nylon mesh to remove possible clusters. 
Subsequently, 50 µl of RNAse (Sigma-Aldrich®, USA) and 50 µl of PI (Fluka, USA) were 
added. This step ensures RNA elimination by RNAse and DNA staining by PI. This 
mixture was left in the tubes in the dark for 15 min and then read in the flow cytometer. To 
measure the fluorescence intensity, samples were analyzed with flow cytometer Coulter 
EPICS XL (Beckman Coulter Inc., Brea, CA, USA) and Attune® Acoustic Focusing 
Cytometer (Applied Biosystems). The number of events reached approximately 5000, for 
each sample. The data were analyzed by FlowJo software (FlowJo LLC, Ashland, OR, 
USA). 
 
5.7. Intracellular ROS detection assay 
For the measurement of the Reactive Oxygen Species (ROS), probe 2’, 7’-
dichlorofluorescin diacetate (DCFH2-DA) (Sigma-Aldrich®) was used. 
Cells were seeded in 6-well plates at the concentration of 1x105 cells/ml and were allowed 
to adhere for 24h. Then cells were exposed to GNPs at the concentration of 5, 50 and 100 
µg/ml, for 24h. After that, cells were washed with PBS and incubated for 30 min at 37°C 
in the dark with serum-free F12K medium with 10µM of DCFH2-DA. Cells were then 
washed with PBS, trypsinized and collected for analysis in the flow cytometer. The 
samples were analyzed with flow cytometer Coulter EPICS XL (Beckman Coulter Inc., 
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Brea, CA, USA) and Attune® Acoustic Focusing Cytometer (Applied Biosystems). The 
data were analyzed by FlowJo software (FlowJo LLC, Ashland, OR, USA).    
 
5.8. Uptake Potential of nanoparticles 
The uptake potential of GNPs by A549 was analyzed by flow cytometry as previously 
described by Bastos et al. (2016). 
Briefly, cells were seeded in 6-well plates at 1x105 cells/ml and allowed to adhere for 24h. 
Cells were then exposed to GNPs at 5 µg/ml, 50 µg/ml and 100 µg/ml and the control were 
exposed to culture medium for 4 and 24h in three different sets. 
The first set was incubated for 4h at 37°C; the second set was incubated for 4h at 4°C (for 
endocytosis inhibition study) and the third was incubated for 24h at 37°C. After the 
incubation period, the cells were trypsinized, ressuspended and collected for flow 
cytometry analysis. Cytometry was performed using the Attune® Acoustic Focusing 
Cytometer (Applied Biosystems). The data were analyzed by FlowJo software (FlowJo 
LLC, Ashland, OR, USA).    
 
5.9. Apoptosis/ Necrosis assay – Annexin V/PI 
Apoptosis was measured by flow cytometry, using the FITC Annexin V Apoptosis 
Detection Kit, from BD Pharmingen™ (BD Pharmingen, San Diego, CA, USA), by double 
staining with Annexin V and PI. This double staining gives us the differentiation between 
early-stage apoptotic cells (Annexin V-FITC (+)/PI(-) cells), from late-stage 
apoptotic/necrotic cells (Annexin V-FITC (+)/PI (+)) and live cells (Annexin V-FITC (-
)/PI (-)). 
Cells were seeded in 6-well plates, at concentrations of 1x105 cells/ml and incubated for 
24h to allow adherence. Then, cells were exposed to the highest concentration of GNPs (in 
this case, 100 µg/ml). Plates were incubated for 24h at 37°C, 5% CO2. 
After exposure, cells were trypsinized and transferred to microtubes. Subsequently, cells 
were washed twice in cold PBS and ressuspended (1x106 cells) in 1x Binding Buffer 
Solution. Following this, 100µl of each cell suspension was transferred to microtubes and 
incubated for 15 min in the dark with 5µl of PI and 5µl of Annexin V. Then, 400µl of 1x 
Binding Buffer Solution were added, and the samples were analysed by flow cytometry. 
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For each sample 10000 cells were analysed and the percentages were calculated from the 
number of cells in each quadrant divided by the total number of cells. For the 
measurements it was used the Attune® Acoustic Focusing Cytometer (Applied 
Biosystems) and data were analyzed by FlowJo software (FlowJo LLC, Ashland, OR, 
USA).    
 
5.10. Statistical Analysis 
At least 3 replicates, and two independent assays were performed for all experiments. Data 
analysis was performed using the software SigmaPlot version 12.0, by one-way ANOVA 
analysis of variance (One-way ANOVA) (p <0.05), followed by a Holm-Sidak test (p < 
0.05) to evaluate the significance of differences in the parameters. 
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6. Results 
6.1. Graphene Nanoplatelets Characterization 
To ascertain the hydrodynamic diameter distribution of the GNPs in cell culture medium, 
we used the DLS. The GNPs supplier did not provide information regarding to the size of 
the nanoplatelets. The hydrodynamic size measurements were performed for the 
concentration of 10 µg/mL in cell culture medium for t=0h, t=2h, t=4h and t=24h. The 
results presented in Table 1 show that over time, the size of the nanoparticles remains 
constant, about 268±6nm. The zeta potential (ζ) of GNPs was measured in ultrapure water 
and in F-12K complete culture medium, with a concentration of 10µg/ml of GNPs. As 
shown in Table 1, GNPs have a strong negative zeta potential in ultrapure water (ζ -37.40 
mV), but in culture medium this value was much less negative (ζ -8.44 mV). The GNPs 
showed a PdI of 0.36 in water, indicating a moderate polydispersion, while in culture 
medium the PdI increased up to 0.49, indicating a broad polydispersion. This may 
demonstrate some degree of agglomeration. 
 
Table 1 – Z-average size (Z-Ave) (with respective polydispersity index PdI) and Zeta 
Potential (ζ) of GNPs dispersed in ultrapure water (Control) or in F-12K culture medium 
(10µg/ml). The standards deviations were calculated from the 3 replicates. 
 
Time (hours) Z-Ave(nm) PdI ζ (mV) 
 
Water (control) 
268.37±8.96 0.36 -37.40±0.72 
0h 
 
 
F-12K 
   
0h 279.03±2.90 0.49 -8.44±2.39 
2h 269.27±3.61 0.49  
4h 261.90±5.65 0.48  
24h 259.47±9.60 0.49  
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Table 2 represents the average size distribution of GNPs when suspended in water and 
complete culture medium. It is possible to observe that there are two peaks, one being 
substantially smaller than the other. This smaller peak is found in a higher percentage in 
the solutions. This results are in agreement with the PdI, showing a polydispersion of sizes.  
 
Table 2 – Average size distribution of GNPs suspended in ultrapure water (Control) and 
complete culture medium (F-12K). The average hydrodynamic size is represented as mean 
diameter (d.) ± standard deviation (SD) in nm. The relative intensities of size peaks are 
indicated in %. 
 
 
Time 
(hrs) 
Peak 1 
d.±SD (nm) 
Peak 2 
d.±SD (nm) 
Peak 3 
d.±SD (nm) 
Peak 1 
% 
Peak 2 
% 
Peak 3 
% 
Water 0 250.2±17.77 2397±2728 - 94 6 - 
F-12K 
0 309.5±5.378 4470±2163 - 97.3 2.7 - 
2 310.5±17.29 4423±2169 8.145±19.95 96.1 3.3 0.6 
4 293.7±3.573 5374±13.08 - 96.9 3.1 - 
24 284.0±21.79 5261±106 - 95.2 2.7 - 
 
 
31 
 
 
6.2. Confluence and Morphology 
A549 cells grow in monolayers until confluence and they have an appearance of cuboidal 
and polygonal cells closely packed. These cells also grow rapidly and consistently as 
observed (they reach confluence in about 3 days). During the exposure period, cells were 
observed under the inverted microscope to verify confluence, morphology and possible 
contaminants. There was no visible loss of confluence, even at higher concentrations 
(Figure 12). However, it is possible to observe some agglomeration by the GNPs, being 
more evident at the higher concentration. 
 
 
 
 
 
 
 
Fig. 12 Light microscopy images of A549 cells exposed to GNP for 24h. A – Control; B - 
5µg/ml; C - 50µg/ml; D - 100µg/ml. 40X. 
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6.3. Cell viability – cytotoxicity assay: WST-8 
To determine cell viability upon exposure to GNPs the WST-8 assay was used and cells 
were analysed after 24h exposure. The protocol was executed according to the information 
provided by Sigma-Aldrich®, with some modifications (Protocol I). To avoid interferences 
in readings from the reagent WST-8 and the medium a background control (without cells) 
was prepared, with typical absorbance between 0.1-0.2 O.D. To correct the values, we just 
subtracted the average absorbance of the background wells from that of the other wells. 
After 24h exposure to the GNPs it was observed a significant increase on cell viability at 
the lowest concentration (5 µg/ml) (p<0.001), with a slight decrease on the other 
concentrations, however without a significant statistical difference (Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subsequently, there were made some modifications to the experiment, according to 
Protocol II. Following 24h exposure, the cells were washed with PBS and added complete 
culture medium with WST-8 to avoid any possible interference from the nanoparticles in 
the culture medium. The O.D. values were slightly lower than those of the previous 
readings, however there was no significant changes on cell viability (p>0.05) (Figure 14).  
* 
Fig. 13. Effects of GNP in A549 cell viability (mean ± standard deviation), for 24h 
exposure, following the WST-8 protocol (Protocol I) * indicates significant differences 
between control at p < 0.05. 
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Nanotoxicity can be caused by nutrient depletion induced by the nanoparticles and so the 
impact of culture medium absorption on the toxicity of GNPs (Protocol III) was tested. For 
this case, data shows an increase on cell viability (p<0.05) (Figure 15) which can 
demonstrate that there is no depletion of nutrients by the GNPs and that in turn the medium 
in contact with the cells is stimulating cell proliferation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Effects of GNP in A549 cell viability (mean± standard deviation), according to 
Protocol II. 
 
* 
Fig. 15. Viability of A549 cells after exposure to F12K medium pre-incubated with 
GNPs for 24h - Protocol III (mean± standard deviation) * indicates significant 
differences between control at p < 0.05. 
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6.4. Intracellular ROS detection 
To evaluate the ability of GNPs to induce oxidative stress, A549 cells were exposed for 
24h with concentrations of 5, 50 and 100 µg/ml. Since there were no changes in cell 
viability, it was not possible to calculate an inhibitory concentration. For this reason, three 
concentrations were chosen to continue the studies: a lower concentration (5µg/ml), an 
intermediate concentration (50µg/ml) and a higher concentration (100µg/ml) (Figure 16). 
Following the exposure time, cells were analysed by flow cytometry, with DCFH2-DA as 
probe. As shown in Figure 17 there were no significant differences between the exposed 
concentrations and the control (p>0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Flow cytometric profile of DCF florescence of A549 cells 
 
 
 
 
 
Fig. 17. Intracellular generation of reactive oxygen species (ROS) by A549 cell, at 
24 h exposure to GNPs (mean± standard deviation). 
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6.5. Cell Cycle Analysis 
To examine if there were alterations in the cell cycle, cells were exposed for 24h and then 
collected for analysis by flow cytometry. The results are presented in Figure 18 and show 
that there is not a significant difference among the cell cycle stages (p>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.6. Cellular Uptake potential of nanoparticles 
The uptake potential of nanoparticles was assessed using flow cytometry. The side scatter 
parameter was used to determine the quantitative analysis of the intracellular signal (Figure 
21). The first set was incubated for 4h at 37°C and the second set was incubated for 4h at 
4°C, for endocytosis inhibition study, with concentrations of 5, 50 and 100µg/ml. The 
results are shown in Figure 19. There was no significant differences between the control 
and the exposed cells (p>0.05). 
 
  
 
 
 
 
 
Fig. 18. Cell cycle analysis of A549 after 24h exposure to GNPs. The values are the 
mean % of cell population (± standard deviation) of the three cell cycle stages. 
 
Fig. 19. Uptake potential of GNPs by A549 cells after 4h exposure at 4°C and 37°C, assessed 
by flow cytometry, using the side scattered light (mean± standard deviation). 
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The third set of cells was incubated for 24h, at 37°C, with concentrations of 5, 50 and 100 
µg/ml. After the exposure time, there was a slight increase in the values of SS, with a 
greater significance to 100 µg/ml relative to the control (p<0.05) (Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
Fig. 20. Uptake potential of GNPs by A549 cells after 24h exposure at 37°C, assessed by 
flow cytometry, using the side scattered light (mean± standard deviation). * indicates 
significant differences between control at p < 0.05. 
* 
Fig. 21. Analysis of the uptake of GNPs by flow cytometry light scatter.  
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6.7. Apoptosis/ Necrosis – Annexin V/PI assay 
To measure the apoptotic/necrotic cells ratio, Annexin V/PI assay was used. The 
measurements were done by flow cytometry using double staining with Annexin V-FITC 
and PI. This double staining allows the differentiation between early-stage apoptotic cells, 
late-stage apoptotic cells, necrotic cells and also viable cells (Figure 22). 
 
A549 cells were exposed to the 100µg/ml of graphene nanoplatelets, for 24h. As shown in 
Figure 23, there were no significant differences in the percentage of cells exposed and the 
control (p > 0.05). 
 
 
 
 
 
 
 
 
 
Fig. 22. Apoptosis evaluation by flow cytometry using Annexin V-FITC and PI 
assay. Scatter diagrams of control (A) and cells exposed to 100µg/ml of GNPs (B). 
Fig. 23. Annexin V-FITC and PI assay for apoptosis assessment of A549 after 24h 
exposure to GNPs. ±SD 
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Discussion 
 
The human exposure to nanomaterials can occur through multiple routes, as for instance 
inhalation, ingestion, skin absorption, injection or implantation, but the major route of 
human exposure to nanomaterials, such as graphene is through inhalation. Therefore, in the 
present study the lung cell line A549 was used as a model with the purpose of ascertaining 
how lung cells can be affected in contact with GNPs.  
Graphene nanoplatelets consist of stacked graphene sheets and usually have a thickness 
between 2-10 nm (Pumera 2009). The characterization results, by DLS, revealed that 
GNPs exhibited a Z-average diameter of 268±6nm in complete culture medium. In water 
was 268.37±8.96nm and slightly increased when the particles were dispersed in culture 
medium, which can indicate particle slight agglomeration or the formation of a protein 
corona. In water the GNPs show a polydispersity index (PdI) of 0.36 indicating moderate 
polydispersion, while in culture medium the PdI increases to 0.49 indicating a broad 
polydispersion, which may indicate some degree of agglomeration. This data are also 
supported by the analysis of the average size distribution that indicates the presence of two 
peaks, with different intensities. As to the zeta potential, GNPs in water carried a strong 
negative surface charge (ζ -37mV), while in culture medium the particles surface was 
considerably less negative (ζ -8.44mV).  The less negative zeta potential indicates that the 
particles are more prone to aggregation. 
Lammel et al. (2013) showed that GO and carboxyl graphene nanoplatelets (CXYG) 
presented different behaviours depending on the supplementation of the culture medium. In 
less supplemented medium (5% of FBS) within 5 min it occurred flocculation and 
formation of aggregates. However, when the medium was supplemented with 10% FBS 
such observations were not found. In another study (Lammel et al. 2014), they used PLHC-
1 cell line in culture medium supplemented with 5% FBS and the particles remained 
dispersed. These observations suggest an optimal concentration of serum between 5-10%, 
where the NPs are stable in culture medium. Though, in this present study, it was noticed 
some agglomeration by GNPs on cell exposure, after 24h incubation. 
In the present study, cellular viability of A549 was accessed by the WST-8 assay (Protocol 
I). The WST-8 assay is a highly water soluble tetrazolium salt and it is used as an indicator 
of cell viability (Tominaga et al. 1999). As described by Tominaga et al. (1999), the WST-
8 assay has a higher sensitivity when  compared with conventional tetrazolium salts, like 
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MTT. A significant increase in cell viability was observed for the lowest GNPs 
concentration (5µg/ml). In a study made by Ahlinder et al. (2015) with A549 cell line, 
where they examined the toxicity of graphene oxide nanoparticles (GONPs), similar results 
were found. The exposure of GONPs for 30h showed a dose-dependent increase in 
fluorescence intensity, and for the lowest concentration (1.56µg/ml) it was observed the 
most significant difference to the control, regarding an increase on cell viability (Ahlinder 
et al. 2015). Hu et al. (2011) analysed the interactions between GO nanosheets and cell line 
A549, reporting that proteins present in the FBS attenuated GO cytotoxicity. A549 cells 
were treated with GO and incubated in RPMI 1640, supplemented with 10% FBS. When 
the supernatant was collected, they found that the amount of serum proteins had decreased 
with the increasing concentration of GO (Hu et al. 2011). These data suggested interactions 
between GO and FBS proteins. Further analysis showed that when cells were exposed to 
GO coated with serum proteins, the cell viability was close to 100%. So, they concluded 
that the serum proteins are capable of reducing the cytotoxicity of GO nanosheets by 
weakening the interactions between GO and the cells. These facts may present a reason 
why there was an increase in cell viability in the present study with GNPs.  
When culture medium with GNPs was removed and cells were washed before addition of 
WST-8 reagent (Protocol II), the O.D. values slightly decreased when compared to the 
values obtained in Protocol I. There were no significant changes in cell viability relative to 
control, upon exposure to GNPs. Therefore, the influence of GNP on cell viability is not 
observed. These results show that there is no increase or decrease in cell viability but that 
there is some interference of the WST-8 reagent and GNPs. 
According to Protocol III, the goal of this assay was to verify if the nanoparticles caused 
nutrient depletion in the culture medium. If the cells did not survive in the medium pre-
treated with GNPs, it could be assumed that there was a toxicity caused by the absorption 
of nutrients by the nanoparticles. However, the results indicate that there is no decrease, 
but rather an increase in cell viability. These data suggest that in some way, the GNPs 
stimulate cell proliferation, which has also been reported by others authors (Ruiz et al. 
2011; Ahlinder et al. 2015). Chang et al. (2011) performed this same protocol, where the 
absorption of nutrients was tested by GO in the A549 cell line. Cells exposed to the 
medium pre-treated with GO showed a proliferation very similar to the control cells. These 
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results suggest that even if there is nutrient absorption by GO, this does not affect the state 
of the cells.  
Liao et al. (2011) studied the cytotoxicity of graphene oxide (GO) and graphene sheets 
(GS) by measuring mitochondrial activity in adherent human skin fibroblasts, using the 
MTT and WST-8 assays. The MTT assay resulted in a false positive signal due to its 
reduction by GO and GS. Previously studies had been described reporting interferences 
between MTT assay and carbon-based materials (Monteiro-Riviere et al. 2006; Wörle-
Knirsch et al. 2006). In addition, Liao et al. (2011) reported that lactate dehydrogenase was 
adsorbed by GO and GS, revealing underestimated results. Through this tests, they found 
that WST-8 would be a good method for evaluate cell viability. However, in the present 
study, it was found that the WST-8 reagent may interfere with the GNPs. 
One of the known mechanisms of nanotoxicity is the formation of reactive oxygen species. 
ROS caused, directly or indirectly, by nanomaterials that can lead to oxidative DNA 
damage, resulting in the activation of mechanisms involved in mutagenesis, carcinogenesis 
and aging related diseases (Fu et al. 2014). ROS production can be influenced by various 
factors such as shape and size of the NPs, particle surface, tendency to aggregate, among 
others (Fu et al. 2014). However, and despite all the data available reporting induction of 
oxidative stress by carbon-based nanomaterials, in this study with A549 cells there were no 
changes regarding the formation of ROS due to GNPs after 24h exposure, even at a highest 
concentration (100µg/ml). 
According to Chang et al. (2011), A549 cells showed induction of oxidative stress when 
exposed to GO, even at low concentrations. Of the three GO samples tested (GO mixture: 
m-GO; GO with smaller size: s-GO and GO with larger size: l-GO), the one that caused the 
most oxidative stress was s-GO (AFM measurements showed a size of 160±90nm; Dh in 
water – 148nm) (Chang et al. 2011). Production of reactive oxygen species by 
nanoparticles can cause oxidative damage to DNA. When this happens, the cells trigger 
their DNA repair mechanisms, or cause cell cycle arrest or even apoptosis (Khanna et al. 
2015). The results obtained in this study do not display changes in cell cycle of A549 when 
exposed to GNPs. Nevertheless, there are some studies that show disturbances in cell cycle 
induced by the interaction with carbon-based nanomaterials. Park et al. (2015) reported an 
increase in a dose-dependent manner in subG1 fraction and S phase, when BEAS-2B cells 
were exposed to GNPs. Increasing in the number of cells in subG1 and S phase indicates 
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apoptosis, which was verified by changes in the levels of proteins associated with cell 
death by apoptosis. 
The cellular uptake potential of GNPs by A549 cells was evaluated by flow cytometry and 
only the highest concentration (100µg/ml) showed a significant difference relatively to 
control, when cells were exposed for 24h at 37°C. This may indicate an uptake of GNPs by 
A549 cells. Park et al. (2015) observed that GNPs were present in the cytosol of BEAS-2B 
cells, after 24h exposure. However, Chang et al. (2011) investigated if GO nanoparticles 
entered A549 cells and the results obtained by TEM did not show nanoparticles inside the 
cells. Identifying the factor that determine the uptake of NPs by the cells is an important 
step towards to the determination of the toxicity of those NPs. However, the studies 
relating to this parameter are few and there is little agreement (Kettler et al. 2014). 
Nevertheless, the internalization of NPs is influenced by their physicochemical 
characteristics and also by the conditions under which the experiments are carried out 
(Kettler et al. 2014). Zhang et al. (2012) analysed the cytotoxicity and cellular uptake of 
MWCNTs, GO and nanodiamond (ND) on HeLa cell line. The results revealed that all the 
compounds were internalized by cells, and ND had a higher uptake ratio, followed by 
MWCNTs and then GO. However, ND induced less cytotoxicity, suggesting that toxicity 
may not be directly related with cellular uptake of carbon nanomaterials. Kostarelos et al. 
(2007) also demonstrated that functionalized carbon nanotubes were easily internalized by 
mammalian and prokaryotic cells. The high aspect ratio and their cylinder shape facilitates 
the entry through the plasma membrane of cells. Protein-coated graphene oxide nanosheets 
(PCGO) were observed, upon SEM examination, to be adherent to surface of mouse 
mesenchymal progenitor C2C12 cells (Mu et al. 2012). By flow cytometry studies (using 
mean fluorescence intensity), it was demonstrated that the cellular uptake of PCGO was 
time and size-dependent. Another study (Ahlinder et al. 2015), used confocal Raman 
spectroscopy to access the interactions between A549 cell line and graphene oxide 
nanoparticles. They found that the NPs were attached to cells, covering a large surface area 
and induced small chemical changes. 
The externalization of phosphatidylserine (PS) is one of the earliest events in apoptosis. 
When apoptosis is induced, the inner PS present in the cell membrane is translocated to the 
outer leaflet of the membrane. The apoptosis assay uses Annexin V to detect PS in the 
external side of the cell membrane. Propidium iodide (PI) is combined with Annexin V to 
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stain necrotic cells, since it is an impermeable dye that only enters the cell and intercalates 
DNA if the cell membrane is compromised. In the present study there was no significant 
increase in the proportion of apoptotic/necrotic cells after treatment with GNPs. This 
results show that GNP did not induce apoptosis/necrosis to A549 cells. Similar results were 
observed by Chang et al. (2011). When A549 were exposed to different sizes of graphene 
oxide (GO) it did not induced any apoptosis or necrosis. Wang et al. (2014) measured 
apoptosis on human multiple myeloma cells (RPMI 8226 cells) when exposed to GO (10, 
50, 100 µg/ml) and they found that there were no significant changes in the apoptosis rate 
after treatment of cells and the control. However, there are other studies with different 
results. For example, Vallabani et al. (2011) analysed the toxicity of GO in normal human 
lung cells (BEAS-2B) and they observed a significant increase of early and late apoptosis 
in exposed cells, when compared to control. Studies (Jaworski et al. 2013) using graphene 
platelets (GP) (100µg/ml) on glioblastoma multiforme cells (U87 and U118) indicated that 
GP induced apoptosis and necrosis to both cell lines. These different results may be related 
to the various forms that exist for the synthesis of graphene. In addition, the type of cells 
analysed may also influence the results. 
The in vivo studies using graphene nanoplatelets demonstrated nanoparticle accumulation 
in the lungs, even after 28 days after the first instillation and sub-chronic inflammation in 
lungs and pleural space (Park et al. 2015; Schinwald et al. 2012). However, there are 
studies that don’t support these results (Kim et al. 2016). 
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Conclusions – Future Perspectives 
The lungs are the primary route of entry of nanoparticles and so, it is crucial to access the 
effects of this compounds on their cells. In this study it was evaluated the cytotoxic 
potential of GNPs on the human lung adenocarcinoma cell line (A549). 
GNPs, analysed by DLS, exhibited some degree of agglomeration, which was supported by 
the values of zeta potential. 
The analysis of cell viability by WST-8 assay showed that GNPs did not affect the cell 
viability of A549 cell line. The cellular uptake of GNPs by A549, assessed by flow 
cytometry, only showed a significant increase in the values of SS for the highest 
concentration (100µg/ml), when cells were exposed for 24h at 37°C. Also, in this study, 
there were no changes regarding the formation of ROS when A549 were exposed to the 
GNPs, even at the highest concentration (100µg/ml). Similar results were observed upon 
the examination of the cell cycle: there were no changes on cell cycle of A549 when 
exposed to GNPs. The results indicate that GNPs did not induce apoptosis/necrosis to 
A549 cells. 
In general, it can be concluded that graphene nanoplatelets did not induce cytotoxicity to 
A549 cell line. 
In future work it would be important to study other forms of graphene, with different 
surface functionalization. Since the lung is a major pathway for the entry of nanoparticles, 
it would be essential to evaluate the cytotoxicity potential of graphene nanoparticles in 
other lung cells models, either primary cell lines or established cell lines. Ultimately, in 
vivo testing could be done in order to understand the pathways these NPs go through once 
inhaled and their interactions with an organism as a whole. Although there are some 
studies in this regard, the results are still inconclusive. 
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